Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Acetylation of platelet cyclooxygenase by oral aspirin is dose dependent and cumulative with repeated administration. However, no single dose of aspirin has been found to be completely selective of platelet thromboxane (TX) synthesis inhibition in man. We determined the dose dependence, cumulative nature and selectivity of aspirin effects on platelet TXB(2) and renal prostaglandin (PG) and prostacyclin (PGI(2)) production. We measured, by radioimmunoassay, serum TXB(2) levels after whole blood clotting and urinary excretion of PGE(2), PGF(2alpha), and 6-keto-PGF(1alpha), before and after single or repeated oral aspirin doses given to 46 healthy subjects. Single doses of 6-100 mg aspirin resulted in a linear (r = 0.92, P < 0.01) inhibition of platelet TXB(2) production, ranging from 12 to 95% after 24 h. A daily dose of 0.45 mg/kg given for 7 d produced a cumulative and virtually complete inhibition of platelet TXB(2) production, without significantly reducing the urinary excretion of PGE(2), PGF(2alpha), and 6-keto-PGF(1alpha) in both healthy men and women. The platelet inhibitory effect of this regimen was maintained unaltered throughout 1 mo of therapy, with no evidence of cumulative inhibition of renal PG-synthesis. Moreover, furosemide-induced renal PGI(2) synthesis and renin release were unaffected by chronic low-dose aspirin. Following cessation of aspirin therapy, platelet TXB(2) production returned toward control values at a similar rate as after a single higher dose. WE CONCLUDE THAT IN HEALTHY SUBJECTS: (a) aspirin causes a dose-dependent inhibition of platelet TXA(2) production, with no obvious sex-related difference; (b) the inhibitory effect of daily low-dose aspirin is cumulative on platelet TXA(2) but not on renal PG-synthesis; (c) during chronic low-dose aspirin therapy, renal PGI(2)-producing cells are readily activable by furosemide at a time of virtually complete suppression of platelet cyclooxygenase activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HABER, E., KOERNER, T., PAGE, L. B., KLIMAN, B., & PURNODE, A. (1969) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-29-10-1349 · Cited by 2,222
Acetylation of prostaglandin synthase by aspirin.
Roth, G. J., Stanford, N., & Majerus, P. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.3073 · Cited by 1,009
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
Patrono, C., Ciabattoni, G., Pinca, E., Pugliese, F., Castrucci, G., De Salvo, A., Satta, M. A., & Peskar, B. A. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90066-3 · Cited by 651
Self-citationA Randomized, Controlled Trial of Aspirin in Persons Recovered From Myocardial Infarction
(1980) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1980.03300330019023 · Cited by 565
Inhibition of platelet prostaglandin synthetase by oral aspirin.
Burch, J. W., Stanford, N., & Majerus, P. W. (1978) · Journal of Clinical Investigation · doi:10.1172/jci108941 · Cited by 558
Urinary prostaglandins. Identification and origin.
Frölich, J. C., Wilson, T. W., Sweetman, B. J., Smigel, M., Nies, A. S., Carr, K., Watson, J. T., & Oates, J. A. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107987 · Cited by 479
Prostacyclin is a circulating hormone
MONCADA, S., KORBUT, R., BUNTING, S., & VANE, J. R. (1978) · Nature · doi:10.1038/273767a0 · Cited by 379
Aspirin Prophylaxis of Venous Thromboembolism after Total Hip Replacement
Harris, W. H., Salzman, E. W., Athanasoulis, C. A., Waltman, A. C., & DeSanctis, R. W. (1977) · New England Journal of Medicine · doi:10.1056/nejm197712082972302 · Cited by 344
DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRIN
Masotti, G., Poggesi, L., Galanti, G., Abbate, R., & Neri Serneri, G. G. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92334-1 · Cited by 284
Estimated rate of prostacyclin secretion into the circulation of normal man.
FitzGerald, G. A., Brash, A. R., Falardeau, P., & Oates, J. A. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110373 · Cited by 269
Renal effects of drugs that inhibit prostaglandin synthesis
Dunn, M. J., & Zambraski, E. J. (1980) · Kidney International · doi:10.1038/ki.1980.179 · Cited by 269
Hanley, S. P., Cockbill, S. R., Bevan, J., & Heptinstall, S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91733-5 · Cited by 195
Acute effects of aspirin and acetaminophen on renal function
Plötz, P. H. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.3.343 · Cited by 37
Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke
H, H. R. (1978) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-197811000-00028 · Cited by 19
Aspirin prophylaxis of venous thromboembolism after total hip replacement
Harris, W. H. (1978) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-197807000-00077 · Cited by 12
Cited by
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
Self-citationCyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., García Rodríguez, L. A., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,218
Self-citationPlatelet Activation in Unstable Coronary Disease
Fitzgerald, D. J., Roy, L., Catella, F., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151602 · Cited by 1,141
Metadata
- Authors
- Patrignani, P., Filabozzi, P., & Patrono, C.
- Venue
- Journal of Clinical Investigation
- Published
- 1982-06-01
- Volume
- 69
- Issue
- 6
- Pages
- 1366-1372
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2125389594
- Cited by
- 937
- References
- 15
- FWCI
- 27.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.